These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 11574213

  • 1. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters.
    Salakou S, Tsamandas AC, Bonikos DS, Papapetropoulos T, Dougenis D.
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):712-21. PubMed ID: 11574213
    [Abstract] [Full Text] [Related]

  • 2. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
    Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D.
    In Vivo; 2007 Oct; 21(1):123-32. PubMed ID: 17354625
    [Abstract] [Full Text] [Related]

  • 3. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
    Shen G, Chai Y, Yue L, Wei HQ, Lin M.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Maximal thymectomy for myasthenia gravis.
    Ashour MH, Jain SK, Kattan KM, al-Daeef AQ, Abdal Jabbar MS, al-Tahan AR, al-Moallami M.
    Eur J Cardiothorac Surg; 1995 Apr; 9(8):461-4. PubMed ID: 7495591
    [Abstract] [Full Text] [Related]

  • 6. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma.
    Zhang M, Zhou Y, Guo J, Li H, Tian F, Gong L, Wang X, Lan M, Li Z, Zhang W.
    Exp Neurol; 2014 Apr; 254():200-5. PubMed ID: 24518487
    [Abstract] [Full Text] [Related]

  • 7. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [Abstract] [Full Text] [Related]

  • 8. [Surgical therapy of myasthenia gravis and thymoma].
    Bertram P, Treutner KH, Winkeltau G, Schumpelick V.
    Chirurg; 1993 Oct; 64(10):796-801. PubMed ID: 8269744
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
    Kanatli I, Akkaya B, Uysal H, Kahraman S, Sanlioglu AD.
    Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
    [Abstract] [Full Text] [Related]

  • 11. A nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).
    Cornea R, Lazăr E, Dema A, Herman D.
    Rom J Morphol Embryol; 2009 Feb; 50(4):729-31. PubMed ID: 19942974
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J, Nakamura S, Nagano I, tobita M, Yoshioka M, Takeda A, Oouchi M, Itoyama Y.
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [Abstract] [Full Text] [Related]

  • 13. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
    Zhang Y, Yu L, Jing Y, Ke J.
    Zhonghua Wai Ke Za Zhi; 2015 Aug 01; 53(8):612-6. PubMed ID: 26653963
    [Abstract] [Full Text] [Related]

  • 14. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
    Chen P, Wang YP, Mou DL, Li ZY, Qu QM, Wang HY, Deng Y, Li XF, Wang T, Xu XH, Zhao G.
    Pathol Oncol Res; 2018 Jan 01; 24(1):67-74. PubMed ID: 28299711
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of thymectomy in myasthenia gravis.
    Hayat G, Mohyuddin YA, Naunheim K.
    Mo Med; 1995 May 01; 92(5):252-7. PubMed ID: 7791734
    [Abstract] [Full Text] [Related]

  • 16. [Diagnosis and therapy of thymus tumors].
    Wolff H, Naundorf M.
    Zentralbl Chir; 1991 May 01; 116(1):3-13. PubMed ID: 2038898
    [Abstract] [Full Text] [Related]

  • 17. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy.
    Nicolaou S, Müller NL, Li DK, Oger JJ.
    Radiology; 1996 Nov 01; 201(2):471-4. PubMed ID: 8888243
    [Abstract] [Full Text] [Related]

  • 18. Modified maximal thymectomy for thymic epithelial tumors: predictors of survival and neurological outcome in patients with thymomatous myasthenia gravis.
    Prokakis C, Koletsis E, Apostolakis E, Zolota V, Chroni E, Baltayiannis N, Chatzimichalis A, Dougenis D.
    World J Surg; 2009 Aug 01; 33(8):1650-8. PubMed ID: 19506940
    [Abstract] [Full Text] [Related]

  • 19. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.
    Bouchikh M, Zouaidia F, Benhaddou EHA, Mahassini N, Achir A, El Malki HO.
    Rev Neurol (Paris); 2017 Jun 01; 173(6):388-395. PubMed ID: 28461027
    [Abstract] [Full Text] [Related]

  • 20. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.
    Nakahara K, Nakane S, Nakajima M, Yamashita S, Mori T, Ando Y.
    J Neuroimmunol; 2017 Apr 15; 305():182-185. PubMed ID: 28100409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.